ATS 2024 Final Program

Click on the session title to view the speakers

326

WEDNESDAY • MAY 22

1004 Similarities Between COPD Gold Stage and E-cigarette Users: A Computational Modeling Comparison of Sputum Soluble Mediator Profiles 1005 Exploring the Relationship Between Body Mass Index, Smoking, and Idiopathic Pulmonary Fibrosis: Insights From a Mendelian Randomization Study 1006 Relighting Characteristics in an Urban, Underserved, and Predominantly Minority Population 1007 The Pittsburgh Vaping Questionnaire: A Novel Instrument to Assess E-cigarette Use in Adults 1008 Disproportionate Use of the Emergency Department by Patients 3-years After EVALI 1009 Evaluation of the Validity and Reliability of the University of California San Diego Inhalant Use Questionnaire 1010 Triple Threat: Examining the Concurrent Use of E-cigarettes, Combustible Cigarettes, and Marijuana and the Public Health Implications 1011 Puff Volume Mediates Heavy Metal Exposure Levels and Oxidative Injury in Ends Users 1012 Effects of E-cigarette Whole Body Aerosol Exposure on Lung Inflammation to an Acute Streptococcus Pneumoniae Challenge in Mice 1013 The Impact of Electronic Cigarettes on Airway Epithelial Barrier Integrity in Preclinical Mouse and Ex Vivo Models 1014 Association of E-cigarette Use With Circulating Eosinophils and Basophils Differs by HIV Serostatus 1015 E-cigarette Users Report Increased Repiratory Symptoms and Dyspnea Compared to Non-users 1016 E-cigarette/Vaping Associated Lung Injury (EVALI) Severity Correlates With Reduced Diffusing Capacity, Need for Lung Biopsy, and Deposition of Titanium in Lung Tissue 1017 Long Term Health Outcomes for Patients With E-cigarette or Vaping Associated Lung Injury (EVALI) Compared to Matched Controls 1018 Cannabis Vapor and Smoke Show Similar Toxic Effects on Human Bronchial Epithelial Cells 1019 Urban-rural Divide in Household Rules Limiting Smoking, Other Tobacco, and E-cigarette Use

1020 Inhalant Usage Patterns in San Diego County 1021 The Relationship Between Cannabis Metabolites and Self-reported Use With Respiratory Symptoms and Spirometry in the Colorado Cannabis Cohort 1022 Save Smoker’s Lungs and Heart: Say Yes to Inpatient Varenicline 1023 Evaluating the Impact of Active Vs Passive Online Recruitment for a Smoking Cessation Program: Leveraging Search and Social Media 1024 Epigenetic Signatures of Cigarette Smoke Exposure in a Murine Model 1025 Effect of Smoking Cessation on COPD-dysregulation of the Alveolar Macrophage Transcriptome

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

D27 LATE BREAKING WAVE! LATE BREAKING ABSTRACTS IN

PULMONARY VASCULAR DISEASE

8:15 a.m. - 10:15 a.m.

San Diego Convention Center Room 25A-C (Upper Level)

Poster Viewing

8:15-9:00

Discussion 9:00-10:15 401 Therapeutic Implications of Plasma Proteome Clusters in Pulmonary Hypertension 402 Phase-resolved Functional Lung-MRI-derived Parameters in Evaluation of Chronic Thromboembolic Pulmonary Hypertension: A Prospective Study 403 Early Markers of Pulmonary Vascular Pathology in Preterm Infants With Bronchopulmonary Dysplasia 404 Impaired Angiogenesis and Its Underlying Mechanisms in Chronic Thromboembolic Pulmonary Hypertension 405 A PAH Drug Ranking Strategy for Individualized Combination Therapy Via Pulmonary Endoarterial Biopsy

ATS 2024 • San Diego, CA